Effect of continuous vagal enhancement on concealed conduction and refractoriness within the atrioventricular node. 1996

R L Page, and J M Wharton, and E N Prystowsky
Department of Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9047, USA.

This study examined the complex interaction between vagal enhancement and how a concealed atrial impulse alters atrioventricular (AV) nodal function. In theory, vagal augmentation could increase or decrease the effect that a premature atrial beat has on the subsequent beat. In 10 patients we established the AV nodal effective refractory period (ERP) without and with a conditioning atrial stimulus (Sc); the stimulation protocol was then repeated after enhancing reflex vagal tone with a continuous phenylephrine infusion. During phenylephrine infusion, the sinus cycle length prolonged from 827 +/- 99 to 1,029 +/- 223 ms (p < 0.001) and AV nodal ERP increased from 331 +/- 51 to 425 +/- 64 ms (p < 0.005). At control, AV nodal ERP in the presence of Sc prolonged to 536 +/- 69 ms (p < 0.001), and during phenylephrine infusion increased to 579 +/- 57 ms (p < 0.01), a change significantly less than during control (58 +/- 14% vs 31 +/- 14%, respectively, p < 0.01). Further experiments suggest that the effect of Sc was reduced because it occurred earlier relative to the vagally prolonged AV nodal ERP. In conclusion, this study demonstrates a complex relation between the timing of a premature atrial beat causing concealed conduction and the degree of vagal tone. The concealed beat, as related to the AV node ERP, has a substantial effect on subsequent AV nodal conduction. These data give insights into clinical AV nodal function.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D012018 Reflex An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D004553 Electric Conductivity The ability of a substrate to allow the passage of ELECTRONS. Electrical Conductivity,Conductivity, Electric,Conductivity, Electrical
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic

Related Publications

R L Page, and J M Wharton, and E N Prystowsky
December 1985, Revista espanola de fisiologia,
R L Page, and J M Wharton, and E N Prystowsky
February 2004, Journal of cardiovascular electrophysiology,
R L Page, and J M Wharton, and E N Prystowsky
March 1985, Heart & lung : the journal of critical care,
R L Page, and J M Wharton, and E N Prystowsky
February 1972, American heart journal,
R L Page, and J M Wharton, and E N Prystowsky
March 1987, Polski tygodnik lekarski (Warsaw, Poland : 1960),
R L Page, and J M Wharton, and E N Prystowsky
March 1993, Pacing and clinical electrophysiology : PACE,
R L Page, and J M Wharton, and E N Prystowsky
June 1971, Circulation,
R L Page, and J M Wharton, and E N Prystowsky
October 1991, Zhonghua yi xue za zhi,
R L Page, and J M Wharton, and E N Prystowsky
August 1979, Circulation,
R L Page, and J M Wharton, and E N Prystowsky
September 1971, American heart journal,
Copied contents to your clipboard!